ANI Pharmaceuticals Inc (ANIP)
Operating profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -4,314 | 8,775 | 47,242 | 54,116 | 48,956 | 45,215 | 26,326 | 3,362 | -25,728 | -54,421 | -57,042 | -62,033 | -39,793 | -15,739 | -9,375 | -5,129 | -16,016 | -21,018 | -16,492 | 4,107 |
| Revenue (ttm) | US$ in thousands | 614,376 | 555,456 | 538,953 | 517,460 | 486,816 | 449,394 | 401,386 | 358,694 | 316,385 | 283,082 | 251,322 | 226,092 | 216,136 | 212,459 | 213,377 | 213,222 | 208,475 | 199,189 | 197,547 | 203,434 |
| Operating profit margin | -0.70% | 1.58% | 8.77% | 10.46% | 10.06% | 10.06% | 6.56% | 0.94% | -8.13% | -19.22% | -22.70% | -27.44% | -18.41% | -7.41% | -4.39% | -2.41% | -7.68% | -10.55% | -8.35% | 2.02% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-4,314K ÷ $614,376K
= -0.70%
The operating profit margin of ANI Pharmaceuticals Inc has shown significant fluctuations over the reported periods.
From March 31, 2020, to December 31, 2022, the company experienced negative operating profit margins, indicating that its operating expenses exceeded its gross profit during these periods. These negative margins ranged from -2.41% to -27.44%, with the largest decline occurring in the first quarter of 2022.
However, starting from March 31, 2023, the trend reversed, and the company began to show positive operating profit margins. The margins improved consistently from 0.94% in March 31, 2023, to 10.46% by March 31, 2024. This turnaround reflects potential cost-cutting measures, revenue enhancements, or operational efficiencies that ANI Pharmaceuticals Inc implemented during this period.
In the latter part of the reported data, from June 30, 2024, to December 31, 2024, the operating profit margin slightly decreased from 8.77% to -0.70%. This decline might suggest some challenges or changes in the company's cost structure or revenue generation strategies during this period.
Overall, the positive trend in operating profit margins from 2023 to 2024 is a positive sign for ANI Pharmaceuticals Inc, indicating improved operational performance and potentially stronger financial health. However, analysts may need to monitor the company's future financial reports to assess the sustainability of this positive trend and identify any underlying factors affecting its operating profit margin.
Peer comparison
Dec 31, 2024